Cargando…

Quadruple Therapy Offers High SVR Rates in Patients with HCV Genotype 4 with Previous Treatment Failure

BACKGROUND AND AIMS: Direct-acting antivirals (DAAs) have made a revolution in hepatitis C virus (HCV) treatment with promising reduction of HCV infection and disease morbidities. However, unfortunately, treatment failure still occurs in about 5–15% of patients treated with DAA‐based combination reg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abo-amer, Yousry Esam-Eldin, Badawi, Rehab, El-Abgeegy, Mohamed, Elsergany, Heba Fadl, Mohamed, Ahmed Abdelhaleem, Mostafa, Sahar Mohamed, Alegaily, Hatem Samir, Soliman, Shaimaa, Elnawasany, Sally, Abd-Elsalam, Sherief
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396033/ https://www.ncbi.nlm.nih.gov/pubmed/32774374 http://dx.doi.org/10.1155/2020/9075905

Ejemplares similares

Serum Dickopff 1 as a Novel Biomarker in Hepatocellular Carcinoma Diagnosis and Follow Up After Ablative Therapy
por: Younis, Yehia Sadek, et al.
Publicado: (2019)

Efficacy and safety of ombitasvir/paritaprevir/ritonavir/ribavirin in management of Egyptian chronic hepatitis C virus patients with chronic kidney disease: A real-life experience
por: Abd-Elsalam, Sherief, et al.
Publicado: (2020)

Declining prevalence of hepatitis C virus among university students in one of the main governorates in Egypt
por: Abo-Amer, Yousry Esam-Eldin, et al.
Publicado: (2018)

Predictors of in-hospital mortality in a cohort of elderly Egyptian patients with acute upper gastrointestinal bleeding
por: Elsebaey, Mohamed A., et al.
Publicado: (2018)

Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt
por: Saleh, Ahmed Mohamed, et al.
Publicado: (2019)

Relationship Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study
por: Abo-Amer, Yousry Esam-Eldin, et al.
Publicado: (2020)

A novel scoring system for prediction of esophageal varices in critically ill patients
por: Hanafy, Amr Shaaban, et al.
Publicado: (2017)

Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study
por: Dabbous, Hany M., et al.
Publicado: (2021)

Retraction Note to: Efficacy of favipiravir in COVID‑19 treatment: a multi‑center randomized study
por: Dabbous, Hany M., et al.
Publicado: (2021)

Randomized Controlled Study Comparing Use of Propofol Plus Fentanyl versus Midazolam Plus Fentanyl as Sedation in Diagnostic Endoscopy in Patients with Advanced Liver Disease
por: Ahmed, Sameh Abdelkhalik, et al.
Publicado: (2017)

A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience
por: Abd-Elsalam, Sherief, et al.
Publicado: (2016)

Association Between Vitamin D Receptor Polymorphism and the Response to Helicobacter Pylori Treatment
por: Abo-Amer, Yousry Esam-Eldin, et al.
Publicado: (2023)

Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals
por: Lin, Chuan-Pin, et al.
Publicado: (2021)

Metformin ameliorated methotrexate-induced hepatorenal toxicity in rats in addition to its antitumor activity: two birds with one stone
por: Rizk, Fatma H, et al.
Publicado: (2018)

Response to “Randomized Controlled Trials on COVID-19 Should be Accurate and Trustworthy”
por: Abd-Elsalam, Sherief, et al.
Publicado: (2022)

Comparative Evaluation of Colon Cancer Specific Antigen-2 Test and Chromocolonoscopy for Early Detection of Egyptian Patients with Colorectal Cancer
por: Elhossary, Marwa, et al.
Publicado: (2020)

Endoscopic injection sclerotherapy versus N-Butyl-2 Cyanoacrylate injection in the management of actively bleeding esophageal varices: a randomized controlled trial
por: Elsebaey, Mohamed A., et al.
Publicado: (2019)

Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia
por: Elbedewy, Tamer A, et al.
Publicado: (2019)

1069. Loss to follow-up does not impact SVR for HCV infection
por: Kottilil, Sita K, et al.
Publicado: (2020)

Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR
por: Yeh, Ming-Lun, et al.
Publicado: (2021)

IL-1α correlates with severity of hepatitis C virus-related liver diseases
por: Tawfik, Ahmed Khaled, et al.
Publicado: (2018)

Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection
por: Ahmed, Ossama A, et al.
Publicado: (2018)

Helicobacter pylori may be an initiating factor in newly diagnosed ulcerative colitis patients: A pilot study
por: Mansour, Loai, et al.
Publicado: (2018)

Efficacy and safety of sofosbuvir–ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection
por: Ahmed, Ossama A, et al.
Publicado: (2018)

Pigtail Catheter: A Less Invasive Option for Pleural Drainage in Egyptian Patients with Recurrent Hepatic Hydrothorax
por: Sharaf-Eldin, Mohamed, et al.
Publicado: (2016)

RETRACTED ARTICLE: Surface modification of thin film composite forward osmosis membrane using graphene nanosheets for water desalination
por: El-Sayed, Fatma Mohamed, et al.
Publicado: (2022)

Retraction Note: Surface modification of thin film composite forward osmosis membrane using graphene nanosheets for water desalination
por: El-Sayed, Fatma Mohamed, et al.
Publicado: (2023)

Prevalence and predictors of abnormal alanine aminotransferase in patients with HCV who have achieved SVR
por: Chadha, Nikita, et al.
Publicado: (2022)

Resolved hepatitis B infection in patients receiving immunosuppressive therapy: Monitor versus prophylaxis against viral reactivation
por: Elsebaey, Mohamed A., et al.
Publicado: (2022)

Remdesivir Efficacy in COVID-19 Treatment: A Randomized Controlled Trial
por: Abd-Elsalam, Sherief, et al.
Publicado: (2022)

Effects of Achieving SVR on Clinical Characteristics and Surgical Outcomes in Patients Who Developed Early-Stage HCV-Related Hepatocellular Carcinoma and Received Curative Resection: Preoperative versus Postoperative SVR
por: Hsu, Po-Yao, et al.
Publicado: (2022)

SVR12 is higher than SVR24 in treatment-naïve hepatitis C genotype 1 patients treated with peginterferon plus ribavirin
por: Thorlund, Kristian, et al.
Publicado: (2014)

HCV and HEV: two players in an Egyptian village, a study of prevalence, incidence, and co-infection
por: Elhendawy, Mohammed, et al.
Publicado: (2020)

Effect of HIV infection-related factors on SVR rate in HCV treatment in HIV-infected patients
por: Kravchenko, Alexey, et al.
Publicado: (2014)

Blood Ammonia Level Correlates with Severity of Cirrhotic Portal Hypertensive Gastropathy
por: El-Kalla, Ferial, et al.
Publicado: (2018)

Pro-Neurotensin as a Potential Novel Diagnostic Biomarker for Detection of Nonalcoholic Fatty Liver Disease
por: Mohamed, Amal A, et al.
Publicado: (2022)

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
por: Vigón, Lorena, et al.
Publicado: (2019)

SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China
por: Li, Yanhua, et al.
Publicado: (2017)

HCV Integrated Care: A Randomized Trial to Increase Treatment Initiation and SVR with Direct Acting Antivirals
por: Groessl, Erik J., et al.
Publicado: (2017)

Dynamics of APRI and FIB-4 in HCV cirrhotic patients who achieved SVR after DAA therapy
por: Leuştean, Anca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0qmjt4d11ng034ublvt9a6m59d